Diabesity Journal Archive
-
Oral Semaglutide 25 mg Shows Significant Weight Loss in Adults With Overweight or Obesity
Published in The New England Journal of Medicine (September 17, 2025) Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has already…
-
Non-Surgical Fat Loss Techniques: Current Approaches and Clinical Considerations
Abstract Non-surgical fat loss techniques, also termed non-invasive body contouring modalities, have gained increasing popularity in recent years as alternatives…
Diabesity Journal Launch
Medical Research Hub
Explore our peer-reviewed articles and research dedicated to diabesity. Our journal aims to advance knowledge and provide a platform for innovative studies in this critical medical field.
Academic Publishing Platform
Our platform offers comprehensive author guidelines and submission instructions to facilitate the publication process for researchers and authors in the field of diabesity.
Open Access Initiative
We are committed to open access, ensuring that all published articles are freely available to the public, promoting wider dissemination of knowledge and research in diabesity.
